In a report released yesterday, Jessica Fye from J.P. Morgan maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...
By Rick Winterson Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge. It has now established its global headquarters on Fan Pier in South ...
Vertex Minerals has initiated the commissioning of a newly installed ore sorter/pre-concentrator at its Hill End Gold plant ...
This was the stock's second consecutive day of losses.
The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...
Zacks.com on MSN5d
Vertex (VRTX) Surges 5.3%: Is This an Indication of Further Gains?Vertex (VRTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
The stock's fall snapped a four-day winning streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback